A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

PARKERSBURG, W.Va. (WTAP) - National Cancer Prevention Month encourages communities to educate themselves on what cancer is.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Three new cancer treatments are to be made available on the NHS in Scotland, as six drugs are given the green light for use.

Cancer prevention isn’t about drastic changes, it’s about small, positive lifestyle habits that improve your well-being. By ...

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.